An Efficacy, Safety and Pharmacokinetics Study of Beloranib (ZGN-440 for Injectable Suspension) in Obese Subjects
Clinical trial NCT01666691 · COMPLETED
Trial details
- NCT number
- NCT01666691
- Sponsor
- Zafgen, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2013-05-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.